Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by Dr_Dan  – Germany, 2015-01-08 09:59 (4188 d 05:52 ago) – Posting: # 14245
Views: 33,959

Dear Detlew
I agree that the study protocol text is insufficiently verbalized. However, if a subject completes two periods, he/she can be included either in the assessment of bioequivalence (in case of one period with test and the other with reference) or in the assessment of within-subject variability of the reference product (in case both periods with reference), right?
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
196 visitors (0 registered, 196 guests [including 15 identified bots]).
Forum time: 16:51 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5